Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system
- 1 May 1999
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 6 (5), 715-728
- https://doi.org/10.1038/sj.gt.3300895
Abstract
Lentiviruses infect both dividing and nondividing cells. In this study we characterized a lentiviral vector system consisting of a packaging vector (pHP) and a transducing vector (pTV) derived from a recombinant human immunodeficiency virus type 1 (HIV-1). In pHP, the long terminal repeats (LTRs), the 5′ untranslated leader and portions of the env and nef genes were deleted. The leader sequence of pHP was substituted with a modified Rous sarcoma virus (RSV) 59 bp leader containing a mutated RSV gag AUG and a functional 5′ splice site. The pHP construct was found to direct Gag-Pol synthesis as efficiently as wild-type HIV-1. The pTV construct contains sequences required for RNA packaging, reverse transcription and integration, but lacks viral genes. Co-transfection of pHP, pTV and a vesicular stomatitis virus G (VSV-G) envelope plasmid produced vectors at titers of 105–106 transducing units per milliliter in 48 h. Replication-competent virus (RCV) was not detected when deletions were made in the env gene in pHP. The ability of this vector system to transduce dividing and nondividing cell in vitro and in vivo was also demonstrated. Compared with a Moloney murine leukemia virus (MLV) vector, the HP/TV vectors transduced human muscle-, kidney-, liver-derived cell lines and CD34+ primary hematopoietic progenitor cells more efficiently. Although the levels of the pTV transgene expression were high soon after transduction, the expression tended to decrease with time due either to the loss of proviral DNA or to the inactivation of promoter activity, which was found to be cell type-dependent. Analyses of extrachromosomal DNA showed that the unintegrated proviral DNA of lentiviral vectors survived much longer than that of the retroviral vectors. We demonstrate that the HP/TV vector is capable of high efficiency transduction and that long-term expression of lentiviral vectors is dependent on target cell type, the internal promoter and the transgene itself in the transducing vector.Keywords
This publication has 28 references indexed in Scilit:
- Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectorsNature Medicine, 1998
- Gene therapy - promises, problems and prospectsNature, 1997
- Development of HIV vectors for anti-HIV gene therapy.Proceedings of the National Academy of Sciences, 1996
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996
- Foamy virus vectorsJournal of Virology, 1996
- Infection and Replication of Tat Human Immunodeficiency Viruses: Genetic Analyses of LTR and tat Mutations in Primary and Long-Term Human Lymphoid CellsVirology, 1995
- Gene therapy using retroviral vectorsCurrent Opinion in Biotechnology, 1994
- Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells.Proceedings of the National Academy of Sciences, 1993
- [40] Use of retroviral vectors for gene transfer and expressionMethods in Enzymology, 1993
- Targeted and highly efficient gene transfer into CD4+ cells by a recombinant human immunodeficiency virus retroviral vector.Journal of Clinical Investigation, 1991